Illumina, Inc. (NasdaqGS: ILMN)
Health Care · Life Sciences Tools & Services · US
$224.84
-0.07% today · +127.7% 1Y
Illumina, Inc. (NasdaqGS: ILMN) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $33.95B and employs 8,600 people.
Over the last twelve months the share price has gained 127.7%, trading between 88.00 and 220.43.
Tweenvest scores Illumina, Inc. across four factors: quality 76/100, value 34/100, growth 25/100. Its strongest factor is quality.
ILMN price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $33.95B
- Revenue (TTM)
- $4.49B
- P/E
- 41.86
- EPS
- 5.37
- Dividend yield
- —
- Beta (5Y)
- 1.46
- 52-week high
- $220.43
- 52-week low
- $88.00
- Avg volume (3M)
- —
- Shares outstanding
- 151.00M
- Employees
- 8,600
- Next earnings
- —
About Illumina, Inc.
Illumina, Inc. specializes in delivering advanced genetic and genomic analysis tools, primarily through sequencing and array technologies. The company's offerings empower clients across various sectors to integrate genomic insights into both research and clinical environments, with applications spanning critical fields like life sciences, cancer diagnostics, reproductive health, agriculture, and innovative new domains. Illumina's portfolio encompasses specialized instrumentation and necessary consumables for genetic analysis, alongside comprehensive genotyping and sequencing services. They also offer instrument maintenance agreements, collaborate through development and licensing deals, and perform cancer detection tests. Its diverse clientele comprises leading genomic research facilities, universities, state-funded laboratories, medical centers, pharmaceutical and biotechnology firms, commercial molecular diagnostic providers, and businesses focused on consumer genomics. Illumina employs a two-pronged distribution strategy, selling directly to clients across North America, Europe, Latin America, and the Asia-Pacific. Additionally, it partners with life-science distributors to reach markets in Europe, the Asia-Pacific, Latin America, the Middle East, and Africa. Established in 1998, the company maintains its corporate headquarters in San Diego, California.
- ISIN
- US4523271090
- Founded
- 1998
- Listed since
- Jul 28, 2000
- Exchange
- Nasdaq Global Select
- Currency
- USD
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Thermo Fisher Scientific Inc.NYSE: TMO | $234.31B | $633.71 | +0.89% |
| Danaher CorporationNYSE: DHR | $151.40B | $215.36 | -0.28% |
| WuXi AppTec Co., Ltd.SHSE: 603259 | $70.42B | CN¥159.25 | -1.09% |
| Samsung Biologics Co.,Ltd.KOSE: A207940 | $51.75B | ₩1,551,000.00 | +0.19% |
| Lonza Group AGSWX: LONN | $50.96B | CHF587.80 | -1.01% |
| Agilent Technologies, Inc.NYSE: A | $43.80B | $155.08 | +0.20% |
| IQVIA Holdings Inc.NYSE: IQV | $43.04B | $261.51 | +0.81% |
| Waters CorporationNYSE: WAT | $40.69B | $414.17 | -0.07% |
Figures last refreshed Aug 18, 2026.